Abstract
Objective To explore the effect and mechanism of apoptosis stimulating protein 2 of p53 (ASPP2) in osteosarcoma metastasis. Methods Quantitative polymerase chain reaction was performed to determine ASPP2 mRNA expression levels in eight samples of human osteosarcoma tissue and four osteosarcoma cell lines. ASPP2 protein levels were detected with western blot. Metastatic ability of SAOS2 cells was assessed using a transwell invasion assay. The β-catenin/E-cadherin interaction was analyzed by co-immunoprecipitation. Immunofluorescence was used to detect nuclear expression of ASPP2 protein in osteosarcoma cells. Results ASPP2 mRNA expression was significantly decreased in eight osteosarcoma tissue samples compared to normal bone tissue collected from the same patients. The levels of ASPP2 mRNA and protein were also significantly decreased in normal human osteoblast cells compared to OS187, SAOS2, HOS, and MG63 osteosarcoma cell lines. Upon ASPP2 overexpression in SAOS2 cells, metastatic ability of cells was reduced, the β-catenin/E-cadherin interaction was enhanced, and nuclear translocation of β-catenin was inhibited. Conclusion ASPP2 reduces the metastatic characteristics of SAOS2 osteosarcoma cells by stabilizing the β-catenin/E-cadherin complex to inhibit β-catenin nuclear translocation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.